(RF) Eurazeo - Overview
Exchange: PA •
Country: France •
Currency: EUR •
Type: Common Stock •
ISIN: FR0000121121
Stock:
Total Rating 13
Risk 36
Buy Signal -1.04
| Risk 5d forecast | |
|---|---|
| Volatility | 27.7% |
| Relative Tail Risk | -1.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.29 |
| Alpha | -49.13 |
| Character TTM | |
|---|---|
| Beta | 0.942 |
| Beta Downside | 1.458 |
| Drawdowns 3y | |
|---|---|
| Max DD | 40.42% |
| CAGR/Max DD | -0.11 |
Description: RF Eurazeo
Eurazeo SE is a private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments. The firm seeks to invest in medium-sized or large companies, SMEs, high growth companies, and real estate management and investment activities. It does not have any restrictions regarding the sectors in which it invests but prefers to invest in smart cities, services, leisure and mobility, real estate, fintech, investment activities, distribution, industry, luxury, consumer goods, business services, consumer and retail brands, and health sectors. The firm seeks to invest in consumer brands with a focus on beauty, digital health, life science, tech, financial services, personal care, household care, juvenile products, apparel, wellness, accessories, home, jewellery, leisure, health, fitness, beverage, and food companies based in United States and Europe. It typically invests in companies with a differentiated concept and global growth potential. The firm identifies companies upstream, carefully selecting them primarily from sectors driven by digital transformation and focusing on changes in lifestyle and consumption (mobility, online buying, collaboration models, etc. The firm invests in large properties in need of restructuring; residential, commercial, and office development projects; and companies with real estate assets in Western Europe. It primarily invests in New York, United States, Paris, France, Italy, North America, China and other European countries. It seeks to invest between '50 million ($54.35 million) to '250 million ($271.77 million) in small mid buyout business. It seeks to invest between '25 million ($27.18 million) and'100 million ($108.71 million) in growth business. It seeks to invest between '10 million ($10.82 million) and '40 million ($43.82 million) in the
Piotroski VR‑10 (Strict, 0-10) 2.0
| Net Income: -711.6m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.00 > 0.02 and ΔFCF/TA 5.34 > 1.0 |
| NWC/Revenue: -281.6% < 20% (prev -5.39%; Δ -276.2% < -1%) |
| CFO/TA 0.00 > 3% & CFO 25.9m > Net Income -711.6m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (70.4m) vs 12m ago -2.82% < -2% |
| Gross Margin: -28.70% > 18% (prev 0.64%; Δ -2935 % > 0.5%) |
| Asset Turnover: 4.85% > 50% (prev 82.25%; Δ -77.40% > 0%) |
| Interest Coverage Ratio: -15.26 > 6 (EBITDA TTM -506.3m / Interest Expense TTM 35.6m) |
Altman Z'' 4.49
| A: -0.14 (Total Current Assets 484.3m - Total Current Liabilities 1.74b) / Total Assets 8.93b |
| B: 0.72 (Retained Earnings 6.41b / Total Assets 8.93b) |
| C: -0.06 (EBIT TTM -542.5m / Avg Total Assets 9.22b) |
| D: 3.30 (Book Value of Equity 6.74b / Total Liabilities 2.04b) |
| Altman-Z'' Score: 4.49 = AA |
Beneish M 1.00
| DSRI: 15.82 (Receivables 243.5m/269.1m, Revenue 446.9m/7.81b) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.99 (AQ_t 0.94 / AQ_t-1 0.95) |
| SGI: 0.06 (Revenue 446.9m / 7.81b) |
| TATA: -0.08 (NI -711.6m - CFO 25.9m) / TA 8.93b) |
| Beneish M-Score: 8.40 (Cap -4..+1) = D |
What is the price of RF shares?
As of February 25, 2026, the stock is trading at EUR 48.04 with a total of 93,995 shares traded.
Over the past week, the price has changed by -3.22%, over one month by -4.68%, over three months by -10.04% and over the past year by -36.66%.
Over the past week, the price has changed by -3.22%, over one month by -4.68%, over three months by -10.04% and over the past year by -36.66%.
Is RF a buy, sell or hold?
Eurazeo has no consensus analysts rating.
What are the forecasts/targets for the RF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 74 | 54% |
| Analysts Target Price | - | - |
RF Fundamental Data Overview February 21, 2026
Market Cap USD = 3.75b (3.18b EUR * 1.1784 EUR.USD)
P/S = 640.9638
P/B = 0.4932
Revenue TTM = 446.9m EUR
EBIT TTM = -542.5m EUR
EBITDA TTM = -506.3m EUR
Long Term Debt = 199.1m EUR (from longTermDebt, last quarter)
Short Term Debt = 1.36b EUR (from shortTermDebt, last quarter)
Debt = 1.63b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b EUR (from netDebt column, last quarter)
Enterprise Value = 4.61b EUR (3.18b + Debt 1.63b - CCE 201.7m)
Interest Coverage Ratio = -15.26 (Ebit TTM -542.5m / Interest Expense TTM 35.6m)
EV/FCF = -1000.0x (Enterprise Value 4.61b / FCF TTM -2.30m)
FCF Yield = -0.05% (FCF TTM -2.30m / Enterprise Value 4.61b)
FCF Margin = -0.51% (FCF TTM -2.30m / Revenue TTM 446.9m)
Net Margin = -159.2% (Net Income TTM -711.6m / Revenue TTM 446.9m)
Gross Margin = -28.70% ((Revenue TTM 446.9m - Cost of Revenue TTM 575.1m) / Revenue TTM)
Gross Margin QoQ = none% (prev 68.72%)
Tobins Q-Ratio = 0.52 (Enterprise Value 4.61b / Total Assets 8.93b)
Interest Expense / Debt = 2.18% (Interest Expense 35.6m / Debt 1.63b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -406.9m (EBIT -542.5m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 0.28 (Total Current Assets 484.3m / Total Current Liabilities 1.74b)
Debt / Equity = 0.25 (Debt 1.63b / totalStockholderEquity, last quarter 6.63b)
Debt / EBITDA = -3.05 (negative EBITDA) (Net Debt 1.55b / EBITDA -506.3m)
Debt / FCF = -672.7 (out of range, set to none) (Net Debt 1.55b / FCF TTM -2.30m)
Total Stockholder Equity = 7.42b (last 4 quarters mean from totalStockholderEquity)
RoA = -7.72% (Net Income -711.6m / Total Assets 8.93b)
RoE = -9.60% (Net Income TTM -711.6m / Total Stockholder Equity 7.42b)
RoCE = -7.12% (EBIT -542.5m / Capital Employed (Equity 7.42b + L.T.Debt 199.1m))
RoIC = -4.70% (negative operating profit) (NOPAT -406.9m / Invested Capital 8.65b)
WACC = 6.76% (E(3.18b)/V(4.81b) * Re(9.39%) + D(1.63b)/V(4.81b) * Rd(2.18%) * (1-Tc(0.25)))
Discount Rate = 9.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.20%
Fair Price DCF = unknown (Cash Flow -2.30m)
EPS Correlation: -53.30 | EPS CAGR: -32.19% | SUE: 0.0 | # QB: 0
Revenue Correlation: -62.77 | Revenue CAGR: -67.72% | SUE: -0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=6.81 | Chg30d=+0.005 | Revisions Net=+1 | Growth EPS=+495.5% | Growth Revenue=+87.1%
P/S = 640.9638
P/B = 0.4932
Revenue TTM = 446.9m EUR
EBIT TTM = -542.5m EUR
EBITDA TTM = -506.3m EUR
Long Term Debt = 199.1m EUR (from longTermDebt, last quarter)
Short Term Debt = 1.36b EUR (from shortTermDebt, last quarter)
Debt = 1.63b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.55b EUR (from netDebt column, last quarter)
Enterprise Value = 4.61b EUR (3.18b + Debt 1.63b - CCE 201.7m)
Interest Coverage Ratio = -15.26 (Ebit TTM -542.5m / Interest Expense TTM 35.6m)
EV/FCF = -1000.0x (Enterprise Value 4.61b / FCF TTM -2.30m)
FCF Yield = -0.05% (FCF TTM -2.30m / Enterprise Value 4.61b)
FCF Margin = -0.51% (FCF TTM -2.30m / Revenue TTM 446.9m)
Net Margin = -159.2% (Net Income TTM -711.6m / Revenue TTM 446.9m)
Gross Margin = -28.70% ((Revenue TTM 446.9m - Cost of Revenue TTM 575.1m) / Revenue TTM)
Gross Margin QoQ = none% (prev 68.72%)
Tobins Q-Ratio = 0.52 (Enterprise Value 4.61b / Total Assets 8.93b)
Interest Expense / Debt = 2.18% (Interest Expense 35.6m / Debt 1.63b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -406.9m (EBIT -542.5m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 0.28 (Total Current Assets 484.3m / Total Current Liabilities 1.74b)
Debt / Equity = 0.25 (Debt 1.63b / totalStockholderEquity, last quarter 6.63b)
Debt / EBITDA = -3.05 (negative EBITDA) (Net Debt 1.55b / EBITDA -506.3m)
Debt / FCF = -672.7 (out of range, set to none) (Net Debt 1.55b / FCF TTM -2.30m)
Total Stockholder Equity = 7.42b (last 4 quarters mean from totalStockholderEquity)
RoA = -7.72% (Net Income -711.6m / Total Assets 8.93b)
RoE = -9.60% (Net Income TTM -711.6m / Total Stockholder Equity 7.42b)
RoCE = -7.12% (EBIT -542.5m / Capital Employed (Equity 7.42b + L.T.Debt 199.1m))
RoIC = -4.70% (negative operating profit) (NOPAT -406.9m / Invested Capital 8.65b)
WACC = 6.76% (E(3.18b)/V(4.81b) * Re(9.39%) + D(1.63b)/V(4.81b) * Rd(2.18%) * (1-Tc(0.25)))
Discount Rate = 9.39% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.20%
Fair Price DCF = unknown (Cash Flow -2.30m)
EPS Correlation: -53.30 | EPS CAGR: -32.19% | SUE: 0.0 | # QB: 0
Revenue Correlation: -62.77 | Revenue CAGR: -67.72% | SUE: -0.07 | # QB: 0
EPS next Year (2026-12-31): EPS=6.81 | Chg30d=+0.005 | Revisions Net=+1 | Growth EPS=+495.5% | Growth Revenue=+87.1%